✦ LIBER ✦

Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

✍ Scribed by Norris, Robin E.; Adamson, Peter C.; Nguyen, Vu T.; Fox, Elizabeth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PARP therapy for the genetically unstabl

✍ Ring, K.L.; Guzman, A.E.; Schmandt, R.E.; Lu, K.H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Safety and tolerability of the poly(ADP-

✍ Jens Samol, Malcolm Ranson, Edwina Scott, Euan Macpherson, James Carmichael, Ann 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 215 KB

Preclinical study of the DNA repair inhi

✍ Flavien Devun; Guilhem Bousquet; Julian Biau; Aurélie Herbette; Christophe Rouli 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 731 KB

584 Preclinical and Clinical Evaluation

✍ Ma, W.; Weekes, C.; Pawaskar, D.K.; Fetterly, G.; Messersmith, W.; Dy, G.; Strau 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Phase 1 dose-escalation study of the PAR

✍ Plummer, Ruth; Stephens, Peter; Aissat-Daudigny, Louiza; Cambois, Anne; Moachon, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 363 KB

Preclinical evaluation of the combinatio

✍ A. S. Yamashita,G. S. Baia,J. S. Y. Ho,E. Velarde,J. Wong… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 729 KB